Takeda Oncology at 2022 American Society of Hematology
Thank you for visiting the Takeda Oncology Newsroom to learn more about research that will be presented at this year’s American Society of Hematology (ASH) congress. At Takeda Oncology, we aspire to cure cancer with inspiration from patients and innovation from everywhere.
Patients with limited or ineffective treatment options motivate us every day. With those patients' needs in mind, we strive to identify promising scientific innovations and to speed the development of life-changing medicines with curative potential.